Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PulseMagic™ TrueForce™ PAF NMPA Study

NCT: NCT07720557 · NOT_YET_RECRUITING

NCT IDNCT07720557
StatusNOT_YET_RECRUITING
Start Date2026-07-10
Completion2028-11-30
SponsorShanghai MicroPort EP MedTech Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑